Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672927 · ClinicalTrials.gov registry record · Phase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
A Phase 4 study of HPV Infection and Human Papillomavirus, sponsored by The University of Texas Medical Branch, Galveston.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 618
- Enrollment target
- 1
- Study location
NCT05672927 is a Phase 4 study of HPV Infection and Human Papillomavirus that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 618 participants, above the 189-participant average among 13 other HPV Infection trials with a reported enrollment target (227% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05672927, a Phase 4 study of HPV Infection and Human Papillomavirus, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 618 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferior immune response. Participants will be randomized 1:1 to either the 2-dose group or the 3-dose group and asked to provide 4 blood samples over a period of 12 months. All 2-dose participants will be offered a 3rd dose after the final blood draw,12 months after their initial vaccination.
Conditions Studied
Interventions
- BIOLOGICAL 9-valent HPV vaccine, 2 doses alternate timing
- BIOLOGICAL 9-valent HPV vaccine, 3 doses standard timing
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 618 participants |
| Start Date | 2023-01-18 |
| Est. Completion | 2027-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05672927
The ClinicalTrials.gov registry entry for NCT05672927 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 618 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 189-participant average among 13 other HPV Infection trials with a reported enrollment target (227% higher). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HPV Infection appearing as the primary indexed condition, and to 2 interventions - of which 9-valent HPV vaccine, 2 doses alternate timing is the first listed.
NCT05672927 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05672927 about?
NCT05672927 is a clinical study titled "Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)". The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferior immune response. Participants will be randomized 1:1 to either the 2-dose group or the 3-dose group and asked to provide 4 blood samples ov...
What is the current status of trial NCT05672927?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 618 participants. The study started on 2023-01-18. Estimated completion is 2027-08.
What conditions does trial NCT05672927 study?
This clinical trial studies the following conditions: HPV Infection, Human Papillomavirus, Immunization.
What interventions are being tested in trial NCT05672927?
The interventions under investigation include: 9-valent HPV vaccine, 2 doses alternate timing (BIOLOGICAL), 9-valent HPV vaccine, 3 doses standard timing (BIOLOGICAL).
Who is sponsoring clinical trial NCT05672927?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05672927 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Immunogenicity of Fractional Dose of the HPV Vaccines
ACTIVE NOT RECRUITING · Phase 4
-
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
ACTIVE NOT RECRUITING · Phase 4
-
Intradermal, Fractional Dose of HPV Vaccines:
ACTIVE NOT RECRUITING · Phase 4
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
PCOM2 - The Physician Communication Intervention, Version 2.0
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.